
|Videos|March 4, 2019
Overcoming Resistance to Venetoclax in AML
Author(s)Sangmin Lee, MD
Sangmin Lee, MD, discusses a potential way to overcome resistance to venetoclax in acute myeloid leukemia.
Advertisement
Sangmin Lee, MD, a physician at Weill Cornell Medicine, discusses a potential way to overcome venetoclax (Venclexta) resistance in acute myeloid leukemia (AML).
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
2
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
3
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
4
Early Relapse Guides Use of CAR T vs Other Options in LBCL
5








































